Immunotherapy & Immuno-Oncology
Part of Healthcare - Oncology
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 JNJ | Johnson & Johnson | $0.6t | $225.21 | -1.0% | 7.9M |
 ABBV | ABBVIE INC. | $377.0b | $198.28 | -0.2% | 7.5M |
 AZN | AstraZeneca PLC | $300.7b | $188.23 | -0.8% | 2.1M |
 MRK | Merck & Co., Inc. | $292.0b | $110.34 | -1.4% | 9.2M |
 AMGN | Amgen Inc | $188.1b | $340.17 | -1.3% | 2.6M |
 BMY | Bristol-Myers Squibb Co. | $122.0b | $57.89 | -1.4% | 10.7M |
 REGN | Regeneron Pharmaceuticals Inc | $79.2b | $744.61 | -0.9% | 603.2K |
 RPRX | Royalty Pharma plc Class A Ordinary Shares | $19.9b | $49.65 | +0.5% | 4.1M |
 MRNA | Moderna, Inc. Common Stock | $19.1b | $48.68 | -4.0% | 6.1M |
 IBRX | ImmunityBio, Inc. Common Stock | $6.8b | $7.30 | -1.9% | 11.1M |
 ACLX | Arcellx, Inc. Common Stock | $6.7b | $115.06 | +0.0% | 16.1M |
 CGON | CG Oncology, Inc. Common stock | $5.4b | $66.87 | -2.6% | 758.0K |
 RCUS | Arcus Biosciences, Inc. | $2.6b | $24.95 | -2.2% | 1.1M |
 SNDX | Syndax Pharmaceuticals, Inc. | $2.0b | $21.00 | -1.9% | 1.3M |
 NKTR | Nektar Therapeutics | $1.9b | $86.78 | -5.4% | 1.6M |
 IOVA | Iovance Biotherapeutics, Inc. Common Stock | $1.4b | $3.42 | -0.6% | 10.3M |
 IMTX | Immatics N.V. Ordinary Shares | $1.2b | $11.33 | -0.2% | 358.3K |
 BCAX | Bicara Therapeutics Inc. Common Stock | $1.2b | $22.45 | -0.9% | 292.7K |
 PGEN | Precigen, Inc. Common Stock | $1.2b | $3.96 | -4.0% | 2.8M |
 CRVS | Corvus Pharmaceuticals, Inc. | $1.1b | $15.92 | -1.0% | 938.5K |
 CTMX | CytomX Therapeutics, Inc. | $1.0b | $4.29 | -2.5% | 2.5M |
 CMPX | Compass Therapeutics, Inc. Common Stock | $0.9b | $1.78 | -64.6% | 158.5M |
 INBX | Inhibrx Biosciences, Inc. Common Stock | $0.9b | $131.07 | +1.6% | 780.8K |
 XNCR | Xencor, Inc. | $0.8b | $13.11 | +1.0% | 1.1M |
 CGEM | Cullinan Therapeutics, Inc. Common Stock | $0.8b | $13.25 | +0.2% | 600.1K |
 JANX | Janux Therapeutics, Inc. Common Stock | $0.8b | $15.24 | +1.5% | 914.0K |
 SLS | SELLAS Life Sciences Group, Inc. Common Stock | $0.7b | $4.89 | +9.6% | 6.5M |
 OMER | Omeros Corporation | $0.7b | $14.76 | +9.1% | 1.9M |
 REPL | Replimune Group, Inc. | $0.6b | $2.69 | +10.9% | 5.7M |
 CBIO | Crescent Biopharma, Inc. Common Stock | $0.5b | $25.09 | +1.2% | 145.7K |
 AURA | Aura Biosciences, Inc. Common Stock | $394.2m | $6.95 | -4.4% | 185.1K |
 CADL | Candel Therapeutics, Inc. Common Stock | $328.1m | $6.31 | -2.9% | 1.4M |
 GLSI | Greenwich LifeSciences, Inc. | $297.7m | $24.12 | -0.4% | 63.2K |
 ALXO | ALX Oncology Holdings Inc. Common Stock | $251.4m | $1.58 | -5.1% | 1.2M |
 CHRS | Coherus Oncology, Inc. Common Stock | $239.8m | $1.84 | +5.1% | 1.0M |
 CNTX | Context Therapeutics Inc. Common Stock | $225.1m | $2.35 | +4.0% | 1.7M |
 CGEN | Compugen Ltd | $188.2m | $2.91 | -6.1% | 926.4K |
 ELTX | Elicio Therapeutics, Inc. Common Stock | $185.4m | $11.53 | -1.4% | 262.8K |
 MGNX | MacroGenics, Inc. | $175.4m | $3.05 | -4.4% | 414.5K |
 AGEN | Agenus Inc. | $124.4m | $4.09 | +4.9% | 1.8M |
 GNLX | Genelux Corporation Common Stock | $103.1m | $2.56 | +1.8% | 123.3K |
 HURA | TuHURA Biosciences, Inc. Common Stock | $97.7m | $2.24 | -4.7% | 931.3K |
 ONCY | Oncolytics Biotech, Inc. Common Shares | $86.6m | $0.96 | -7.1% | 6.1M |
 ANIX | Anixa Biosciences, Inc. | $83.8m | $2.96 | -3.0% | 122.8K |
 MAIA | MAIA Biotechnology, Inc. | $79.5m | $1.27 | 0.0% | 686.5K |
 XBIT | XBiotech Inc | $69.2m | $2.59 | +3.2% | 33.1K |
 BYSI | BeyondSpring Inc. Ordinary Shares | $66.6m | $1.57 | -7.9% | 18.4K |
 IBO | Impact BioMedical, Inc. | $63.1m | $0.66 | +1.1% | 35.4K |
 TIL | Instil Bio, Inc. Common Stock | $54.1m | $8.26 | +2.5% | 9.2K |
 PDSB | PDS Biotechnology Corporation Common Stock | $51.8m | $0.93 | +3.8% | 511.9K |